Overview
Animal models are non-human organisms used to study biological processes, model human disease, and evaluate the safety and efficacy of interventions under controlled conditions before clinical application. They range from rodents and larger mammals to fish and invertebrates, and may be naturally occurring, surgically or chemically induced, or genetically engineered to recapitulate specific pathologies. Animal models support mechanistic investigation, drug discovery, and toxicology, complemented increasingly by in silico and in vitro approaches and by ethical frameworks promoting refinement and replacement. The peer-reviewed research collected here employs and discusses animal models across many applications, including histo-morphological effects of plant extracts on gastrointestinal tissue, deep brain stimulation targets for epilepsy treatment, synthesis and evaluation of a tuberculosis imaging agent, development of cellular and molecular biomarkers using probiotic bacteria, and experimental zoology and drug-design progress spanning in silico, in vitro, and in vivo research. Further contributions address gene therapy for heart failure, animals in the COVID-19 era as source and sentinel, alternative-to-animal disease modeling platforms, and a novel analgesic drug candidate. Recurring themes include disease modeling, preclinical drug and biomarker evaluation, toxicological testing, and the ethical evolution toward complementary non-animal methods. Together these contributions frame animal models as essential tools that bridge basic biology and clinical translation, enabling controlled study of disease mechanisms and therapeutic candidates while increasingly integrated with emerging alternative approaches.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Drug Design Progress of In silico, In vitro and In vivo Researches
Search for New Targets of Deep Brain Stimulation for Epilepsy Treatment
Synthesis of Labeled Rifabutin Dithiocarbamate: A Potential Mycobacterium Tuberculosis Imaging Agent
Developing Cellular & Molecular Biomarkers for Anti-Inflammatory Activities of Probiotic Bacteria in Fermented Foods
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Experimental Zoology. Advancements, Problems and Future Prospects
Current Status and Future Perspectives of Gene Therapy for Heart Failure
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Bioinformatic Resources for Diabetic Nephropathy
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Novel N-Pyrrolylcarboxylic Acid Derivative as a Potential New Analgesic and Anti-Inflammatory Drug
How this research is being cited
The 12 articles above have been cited 31 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Journal of Computational Biophysics and Chemistry
-
2023 · Journal of Computational Biophysics and Chemistry
-
2022 · Pharmaceutical Chemistry Journal
-
2022 · Pharmaceutical Chemistry Journal
-
Fang Zhang et al. · 2021 · Frontiers in Neurology
-
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review2021 · International Journal of Coronaviruses
-
2021 · Neuroscience Letters
-
2021 · Frontiers in Neurology
A sample of recent works citing this journal's research on Animal Models, linking to each citing work.